Investigating hearing problems related to myelination in Fragile X Syndrome
Myelination Deficits Underlying Auditory Issues in Fragile X Syndrome
This study is looking at how problems with myelination, which is important for nerve function, affect how people with Fragile X Syndrome hear and process sounds, with the hope of finding ways to help improve their listening skills.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma State University Stillwater NIH-funded |
| Lab location | 1 site (Stillwater, United States) |
| Project ID | NIH-10201325 on NIH RePORTER |
What this research studies
This research focuses on understanding how myelination deficits affect auditory processing in individuals with Fragile X Syndrome, a genetic condition associated with autism. The study examines the auditory brainstem circuit, which is crucial for processing sound information from both ears. By using various methods such as anatomical analysis, physiological recordings, and behavioral tests, the researchers aim to uncover the mechanisms behind these auditory issues. The findings could lead to better insights into how auditory processing can be improved in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Fragile X Syndrome, particularly those experiencing auditory processing challenges.
Not a fit: Patients without Fragile X Syndrome or those not experiencing auditory issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved interventions for auditory processing difficulties in patients with Fragile X Syndrome.
How similar studies have performed: Previous research has shown promising results in understanding auditory processing deficits in autism, suggesting that this approach may yield valuable insights.
Where this research is happening
Stillwater, United States
- Oklahoma State University Stillwater — Stillwater, United States (Active)
Researchers
- Principal investigator: Mccullagh, Elizabeth Anne — Oklahoma State University Stillwater
- Study coordinator: Mccullagh, Elizabeth Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.